fda warning letters glp-1 compounding october 2025 issued 25 to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Congress Introduces SAFE Drugs Act

4.5 Impact of SGLT-2 inhibitors and GLP-1 receptor agonists on kidney function Multiple clinical trials have demonstrated the renoprotective effects of SGLT-2i and GLP-1 RAs in patients with T2DM and CKD

Beyond reproductive issues, PCOS increases the risks of type 2 diabetes, cardiovascular diseases, metabolic syndrome, and mental health disorders, significantly impacting quality of life and healthcare utilization [3]

From the initial consultation to long-term management, every aspect of your care is designed to optimize testosterone levels safely, effectively, and sustainably

Note: This product is for research use only and is not intended for diagnostic, therapeutic, or clinical use